UNSPSC 51421701: Corticorelin ovine triflutate

This classification denotes a crh gene with the molecular formula C208H344N60O63S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 305OE8862Y, chemically known as l-alaninamide, l-seryl-l-glutaminyl-l-alpha-glutamyl-l-prolyl-l-prolyl-l-isoleucyl-l-seryl-l-leucyl-l-alpha-aspartyl-l-leucyl-l-threonyl-l-phenylalanyl-l-histidyl-l-leucyl-l-leucyl-l-arginyl-l-alpha-glutamyl-l-valyl-l-leucyl-l-alpha-glutamyl-l-methionyl-l-thronyl-l-lysyl-l-alanyl-l-alpha-aspartyl-l-glutaminyl-l-leucyl-l-alanyl-l-glutaminyl-l-glutaminyl-l-alanyl-l-histidyl-l-seryl-l-asparaginyl-l-arginyl-l-lysyl-l-leucyl-l-leucyl-l-alpha-aspartyl-l-isoleucyl- but generally known as corticorelin, which bears US NIH Compound Identifier 16132344.

UNSPSC 51421701 Corticorelin ovine triflutate is a Commodity code that shows a mismatch between its nominal pharmaceutical scope and recent state and local procurement activity. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems for community health initiatives, not corticorelin ovine triflutate. The county seeks 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year initial term with a one-year renewal option.

Seminole County's procurement is the only recent documented activity under this code. The IFB requires electronic bid submission through the county's e-procurement portal with a response deadline of July 26, 2023, at 2:00 pm. Vendors must provide unit costs, carry workers' compensation and commercial general liability insurance, comply with E-Verify requirements and drug-free workplace certification, and include all shipping and delivery costs in their proposals. The procurement was potentially FEMA-funded and therefore subject to federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The code shows minimal recent activity and no clear alignment with its stated pharmaceutical commodity name, suggesting either a tagging error or limited state and local procurement demand under this specific code.